The hunt for nutritional and pharmacological modulators of paraoxonase

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 8, 2002, Pages 1248-1250

  Durrington, P N ^a   Mackness, B ^a   Mackness, M I ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKADIENE; ALPHA TOCOPHEROL; AMINO ACID; ANTILIPEMIC AGENT; ANTIOXIDANT; APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE; ASCORBIC ACID; CHOLESTEROL; CHOLESTEROL ESTER; FIBRIC ACID DERIVATIVE; GLABRIDIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; MONOUNSATURATED FATTY ACID; ORGANOPHOSPHATE; QUERCETIN; RECEPTOR; TOXIN; VITAMIN;

ALLELE; CLINICAL TRIAL; EDITORIAL; ENZYME ACTIVITY; GENETIC POLYMORPHISM; HUMAN; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION; NONHUMAN; NUTRITION; PRIORITY JOURNAL; SMOKING;

ARTERIOSCLEROSIS; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET; ESTERASES; HUMANS; LIPID PEROXIDATION;

EID: 0036343934     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000027414.34728.1F     Document Type: Editorial

References (43)

1. Atherosclerosis
2. Dietary and pharmacological antioxidants in atherosclerosis
3. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
4. Vitamin E supplementation and cardiovascular events in high-risk patients
5. Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis?
6. Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients
7. Vitamin E supplementation increases the resistance of both LDL and HDL to oxidation and increases cholesteryl ester transfer activity
8. CETP and atherosclerosis
9. Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesion in a rabbit model of atherosclerosis
10. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits
11. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
12. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein
13. The role of highdensity lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation
14. Human serum paraoxonase (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities
15. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
16. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
17. Lack of protection against oxidative modification of LDL by avian HDL
18. Presence of paraoxonase in human interstitial fluid
19. On the ability of high density lipoproteins to remove phospholipid peroxidation products from erythrocyte membranes
20. Paraoxonase and atherosclerosis
21. Human serum paraoxonase
22. Paraoxonase status in coronary heart disease: Are activity and concentration more important than genotype?
23. Vitamin C and E intake is associated with increased paraoxonase activity
24. Dietary determinants of serum paraoxonase activity in healthy humans
25. Human serum paraoxonase (PON1) is inactivated by oxidised low density lipoprotein and preserved by antioxidants
26. Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease
27. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
28. Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type I diabetes mellitus
29. Dietary fat modulates serum paraoxonase I activity in rats
30. Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat
31. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model
32. Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits
33. Pomegranate juice consumption reduces oxidative stress, atherogenic modification of LDL, and platelet aggregation: Studies in humans and in atherosclerotic apolipoprotein E-deficient mice
34. Daily moderate alcohol consumption increases serum paraoxonase activity: A diet controlled, randomised intervention study in middle-aged men
35. Relationship of age-related myocardial infarction risk and G1n/Arg 192 variants of the human paraoxonase gene: The Regicor study
36. Effect of organophosphate intoxications on human serum paraoxonase
37. Promoter polymorphisms of human paraoxonase PON1 gene and serum activities and concentrations
38. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients
39. Atorvastatin and gemfibrozil metabolites, but not the parent drugs are potent antioxidants against lipoprotein oxidation
40. Effect of gemfibrozil on HDL-associated serum paraoxonase activity and lipoprotein profile in patients with hyperlipidaemia
41. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia
42. Effect of simvastatin on serum paraoxonase activity
43. Changes in paraoxonase and apolipoprotein A-1, B, C-III and E in subjects with combined familial hyperlipoproteinaemia treated with ciprofibrate